Clinical characteristics, outcomes, and management of COVID-19 in kidney transplant recipients across Asia: an ASTREGO report

. 2021 Dec 31;35(4):218–229. doi: 10.4285/kjt.21.0024

HIGHLIGHTS
This is the first multi-national Asian study of coronavirus disease 2019 (COVID-19) infections. The study population comprised of younger kidney transplant recipients with a lower comorbidity burden. Asymptomatic patients were frequent, but progression to more severe disease was uncommon. Mortality from COVID-19 remained high despite a population likely to have a lower risk of progression. There may be other factors affecting mortality in Asia such as timely access to higher levels of care.

HIGHLIGHTS

This is the first multi-national Asian study of coronavirus disease 2019 (COVID-19) infections.
The study population comprised of younger kidney transplant recipients with a lower comorbidity burden.
Asymptomatic patients were frequent, but progression to more severe disease was uncommon.
Mortality from COVID-19 remained high despite a population likely to have a lower risk of progression.
There may be other factors affecting mortality in Asia such as timely access to higher levels of care.